Cano Health Q3 2023 Gaap EPS $(91.87) Misses $(18.50) Estimate, Sales $788.07M Beat $757.20M Estimate
Author: Benzinga Newsdesk | November 09, 2023 06:24pm
Cano Health (NYSE:
CANO) reported quarterly losses of $(91.87) per share which missed the analyst consensus estimate of $(18.50) by 396.59 percent. This is a 39843.48 percent decrease over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $788.07 million which beat the analyst consensus estimate of $757.20 million by 4.08 percent. This is a 18.51 percent increase over sales of $665.00 million the same period last year.
Posted In: CANO